CFDE Data Portal | Search CRISPLD1

	Label	Description
	CRISPLD1 Gene (Entity type)	ENSG00000121005 - cysteine rich secretory protein LCCL domain containing 1
	PLOD3 Gene (Entity type)	ENSG00000106397 - procollagen-lysine,2-oxoglutarate 5-dioxygenase 3
	CRISPLD1 associations Collection (Entity type)	Associations for CRISPLD1_associations
	CRISPLD1 Up Gene Set (Entity type)	A Gene Set from LINCS
	CRISPLD1 Down Gene Set (Entity type)	A Gene Set from LINCS
	CRISPLD1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	IL10RB Gene (Entity type)	ENSG00000243646 - interleukin 10 receptor subunit beta
	PSMD4 Gene (Entity type)	ENSG00000159352 - proteasome 26S subunit ubiquitin receptor, non-ATPase 4
	ADCY3 Gene (Entity type)	ENSG00000138031 - adenylate cyclase 3
	PAFAH1B3 Gene (Entity type)	ENSG00000079462 - platelet activating factor acetylhydrolase 1b catalytic subunit 3

CRISPLD1

ENSG00000121005 - cysteine rich secretory protein LCCL domain containing 1

PLOD3

ENSG00000106397 - procollagen-lysine,2-oxoglutarate 5-dioxygenase 3

CRISPLD1 associations

Associations for CRISPLD1_associations

CRISPLD1 Up

A Gene Set from LINCS

CRISPLD1 Down

A Gene Set from LINCS

CRISPLD1 associations.tsv

A file from IDG as part of the Harmonizome project

IL10RB

ENSG00000243646 - interleukin 10 receptor subunit beta

PSMD4

ENSG00000159352 - proteasome 26S subunit ubiquitin receptor, non-ATPase 4

ADCY3

ENSG00000138031 - adenylate cyclase 3

PAFAH1B3

ENSG00000079462 - platelet activating factor acetylhydrolase 1b catalytic subunit 3

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.